ViiV Culture=Backstabbing

Most of the tenured ViiV reps are going through the motions along with the RSD to protect the gsk salary.

Juluca is a dog and Triumeq is dying.

The new ViiV reps work hard but the tenured reps don’t want any help because it exposes the 2 calls per,day.

Sorry, I am newer to,ViiV and wish more,worked.

Ms Waterhouse please see this.

 

Can’t disagree with above. Truth be told, with Triumeq dying and Juluca dead on arrival, it wouldn’t matter how hard people worked. Nothing in the near or distance future makes me feel any better in regards to potential products to sell. I think it’s just a matter of hanging on and trying to lose less market share than my peers here at GSK. It’s no longer a matter of selling what’s new, because it sucks. I just pray to hold on to most of what I have.

 

Greater R&F and more fake C2W from RSD will save the day along with best practices from fieldtrainers during calls. It worked in the 80s. Larger teams a must

 

VIIV simply adopted GSK model of RF on a bunch of busy work that have zip to do with sales. I jumped from respiratory for a better culture. It’s as bad or worse. The difference is selling a dog now.

 

when layoffs come in HIV near the end of this year, will they be based on tenure? Performance with all products or just Juluca (I hope not Juluca, otherwise we are all goners). Will volume of territory dictate we go 3 to 2 or 3 to 1.5?

 

If anything like the GSK layoffs in the past territory volume will be part of it. The RSDs don’t have a say. It always seemed very random to me

 

Gilead look out. Our yuge pod teams will smash Biktarvy with injectable. Hehehe. https://seekingalpha.com/article/4201183-gilead-debate-focused-threat-gsk-hiv-management-departures

 

i hope the injectables do well. I see these as only slightly more mainstream than these 2 drug dogs we are pushing. Even so, our Yuge Pods are too big. Good luck to all in the impending HIV job cuts.

 

I am looking now. I see no way HIV stays with this many reps. The current 2 drug regimine isn’t selling at all in my territory, and I know it will be the same with next year’s product. I can’t wait around for an injectable. I fear our goals won’t be realistic with this niche product. I figure with the job market as good as it is now, now is the time to look. Good luck to all over the next couple months in HIV, it’s going to be a rough ride!

 

I want the injectable to succeed, but still a 2 drug dog CAB/RPV. Unless Juluca does better worried that docs won’t use injection. Sad that ViiV used to be the place to be but now the morale is so dead and fake. Respiratory RSDs ruined it.

 

advanced training for both new hire groups from last year canceled for ViiV. A bit concerning.

 

BMS was tough but paid for sales. Here I get harassed for s**t Juluca sales but don’t get paid more for the sales. ViiV sucks

 

Quite concerning. Layoffs are inevitable. It’s hard for me to sell with a straight face right now. I believe Triumeq has its place, and Dolutegravir is a really good drug, Juluca is an absolute joke. We are going backwards with this sh@tshow, and the 2 drug combo’s to follow.

 

We run off good people. ViiV has a toxic culture that pits new TAMs against existing TAMs. RSDs falsify. Keep C2W

 

DTG is a great drug. RPV, lamivudine, no. CAB, no. Injectable 2 dog regimen is going to suck if this continue.

3rd useless rep made things worse.

 

This isn’t a curt or smug remark, but this is not the first time this has happened to a company and it’s sales force - Viiv got outmaneuvered by its competitor.

 

How's the US Sr. Leadership team with Bill gone?

 

Bill, Marlon, Colleen signed off on a expansion where access already stunk. Course they were clueless because everyone enters “calls” whether seeing customer or not. No see customers do not exist. The company paid on R & F so we gave it to them. Now Triumeq, Tivicay, and dog on arrival Juluca are getting killed the company is beating us up on sales. Bonus will stink as we won’t make national goal. Bill and Marlon retired while th getting is good leaving us with terrible RSDs and crap culture

 

Sad but on point. Unfortunate for us as ViiV sales are too low to support all of us. DTG is great, but someone inside had to know that Tivicay and Descovy are popular combo for a reason. not RPV or lamividine.

 

I SAID BRACE